NEW YORK , Nov. 14, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global photodynamic therapy (PDT) market size is estimated to grow by USD 2.35 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 8.69% during the forecast period. High prevalence of cancer is driving market growth, with a trend towards increase in R and D and advances in technology.
However, high cost of treatment poses a challenge.Key market players include Bausch Health Companies Inc., Biofrontera AG, BIOLASE Inc.
, biolitec AG, Eufoton srl, Galderma SA, II VI Inc., IRIDEX Corp., Lotus Global Group Inc.
, LUMIBIRD SA, Lutronic Inc., Modulight Inc., Photocure ASA, Pinnacle Biologics Inc.
, Quanta System S.p.A.
, Soligenix Inc., SpectraCure AB, Sun Pharmaceutical Industries Ltd., SUS Advancing Technology Co.
Ltd., and Theralase Technologies Inc..
AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View Free Sample Report PDF Key Market Trends Fueling Growth The photodynamic therapy market is experiencing significant growth due to advancements in research and development. Vendors are investing in novel therapies for cancer treatment, including photodynamic therapy, which offers reduced toxicity for patients with skin conditions.
Technological innovations, such as DNA sequencing and drug delivery methods, have improved disease detection and treatment, le.
